T-Net2h
Lexaria Updates its Ongoing Human Study GLP-1-H24-4
Lexaria Bioscience Corp., a global innovator in drug delivery platforms, provided progress updates on its Phase 1b, 12-week ...
T-Net1h
InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study
InMed Pharmaceuticals Inc., a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug ...
T-Net2h
Zymeworks Announces $50 Million Private Placement with EcoR1 Capital, Proceeds Expected to Extend Cash Runway Into H2 2027
Zymeworks Inc., a clinical-stage biopharmaceutical company developing novel, multifunctional biotherapeutics, announced that it has entered into a securities purchase agreement with funds affiliated ...
T-Net2h
Photonic Accelerates Timeline to 'Useful Quantum Computing' With Industry First Breakthrough Results in Error Correction
In an industry first, Photonic Inc. announced that it has introduced a new, low-overhead family of Quantum Low-Density Parity Check (QLDPC) codes that can efficiently perform both quantum computation ...
T-Net1d
Vancouver-based Early-Stage VC Firm GTMfund Raises $79 Million (US $54 Million) Second Fund
GTMfund announced that it has raised an oversubscribed Fund II of $78.83 million (US $54 million). GTMfund is an early-stage ...
T-Net1d
Invinity Energy Systems Announces Release of Next-Gen Modular Vanadium Flow Battery ENDURIUM to Transform Grid-Scale Energy Storage
Invinity Energy Systems has announced the commercial release of ENDURIUM, their next-generation modular vanadium flow battery. ENDURIUM builds on the company's experience of three generations of flow ...
T-Net4d
Innovate BC Appoints Elizabeth Dutton as Chief Operating Officer
Innovate BC has announced Elizabeth Dutton as its new Chief Operating Officer (COO). In this role, Dutton will provide strategic leadership to the organization, focussed on operational efficiency, ...
T-Net2d
Algernon NeuroScience Appoints Validcare as CRO for its Phase 2a DMT Human Stroke Trial, Announces Validcare’s $250K Equity Investment
Algernon Pharmaceuticals Inc., a Canadian clinical stage pharmaceutical development company, announced that its wholly owned subsidiary, Algernon NeuroScience (AGN Neuro), has appointed Validcare as ...
T-Net3d
WELL Health Technologies Provides Corporate Update on Financial Performance of its Acquired Canadian Clinics
WELL Health Technologies Corp., a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, ...
T-Net5d
Corvus Energy to Power World's First Fully Electric Offshore Vessel With Mega-Size Battery System
Corvus Energy, a leading supplier of zero emission solutions for the offshore and marine industry, announced that it will ...
T-Net3d
DIGITAL Announces Expansion of Support for Canadian Talent Development
DIGITAL, Canada's Global Innovation Cluster for digital technologies, announced that it is expanding 12 partnerships with Canadian employers and training providers that will deliver skilling ...
T-Net3d
Vecima Announces Preliminary Second Quarter Fiscal 2025 Results
Vecima Networks Inc. announced that its second quarter financial results will reflect impacts related to adjustments in the timing of some of its largest customers' cable and fiber upgrades, as well ...